Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ChREBP Polyclonal Antibody, DyLight™ 488
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA522923
Description
The target sequence has 83% sequence homology with mouse ChREBP.
ChREBP is a transcription factor involved in activating genes that encode enzymes of fatty acid biosynthesis in liver and adipose. This protein may have relevance to lipid metabolism, obesity, and type II diabetes.
Specifications
ChREBP | |
Polyclonal | |
DyLight 488 | |
MLXIPL | |
BHLHD14; carbohydrate response element binding protein; carbohydrate-responsive element-binding protein; ChREBP; Class D basic helix-loop-helix protein 14; MIO; MLX interacting protein like; MLX interacting protein-like; MLX interacting protein-like beta; Mlx interactor; MLX-interacting protein-like; MLXIPL; MONDOB; putative hepatic transcription factor; WBSCR14; Williams Beuren syndrome chromosome region 14; williams-Beuren syndrome chromosomal region 14 protein; Williams-Beuren syndrome chromosomal region 14 protein homolog; Williams-Beuren syndrome chromosome region 14 homolog; Williams-Beuren syndrome chromosome region 14 protein 1; Williams-Beuren syndrome chromosome region 14 protein 2; Williams-Beuren syndrome chromosome region 14 protein 3; WS basic-helix-loop-helix leucine zipper protein; WS-bHLH | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
171078, 51085, 58805 | |
4°C, store in dark | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1 mg/mL | |
50mM sodium borate with no preservative | |
Q8VIP2, Q99MZ3, Q9NP71 | |
MLXIPL | |
An C-terminal synthetic peptide made to the human ChREBP protein sequence (between residues 800-852). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction